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We investigated zinc and copper levels in angiographically defined obstructive coronary
artery disease (CAD) in patients undergoing elective coronary angiography in El-Shaab
Hospital, Sudan. We performed a cross-sectional study. One hundred forty-two patients
were enrolled. Sociodemographic and medical characteristics were collected using
a questionnaire. Glucose, lipid, zinc, and copper levels were measured. Out of 142
patients, 102 (71.8%) had CAD and 40 (28.2%) had patent coronary arteries. There
were no significant differences in median (interquartile range) zinc [118.5 (97.2–151.0)
vs. 130.0 (106.0–174.0) µg/ml, P = 0.120] and copper [150.6 (125.0–183.0) vs.
158 (132.0–180.0) µg/mL, P = 0.478] levels between patients with CAD and those
with patent coronary arteries. In linear regression analysis, there were no associations
between CAD and zinc and copper levels. The current study failed to show any significant
association between CAD and zinc and copper levels.
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Introduction
Coronary artery disease (CAD) is a large health problem worldwide and one of the leading
causes of morbidity and mortality (Yusoff, 2002). Traditional risk factors of CAD, such as
hypercholesterolemia, hypertension, and smoking, account for≤50% ofmortality (Gey et al., 1991).
Therefore, other factors that might be involved in the pathogenesis of CAD need to be determined.
There is growing evidence that oxidative free radicals play a role in the pathogenesis of CAD (Ames
et al., 1993). Similarly, trace elements (e.g., zinc and copper) have also been implicated in the
pathogenesis of CAD (Lukaski et al., 1988; Reunanen et al., 1996; Cebi et al., 2011). Research on
zinc and copper in patients with CAD is important because these trace elements may be useful
predictors for CAD and their levels might be able to be adjusted to prevent this disease. We have
previously studied zinc and copper in different diseases in Sudan (Abdelrahim et al., 2009; Bushra
et al., 2010; Mohamed et al., 2011); however, levels of these elements were not explored in Sudanese
patients with CAD.
In Sudan, CAD is a large health problem. Coronary catheterization centers are mostly confined
to the capital, Khartoum state. There are no published data on trace elements among Sudanese
patients with CAD (Suliman, 2011; Musa et al., 2013). The current study aimed to investigate zinc
and copper levels in patients undergoing elective coronary angiography because of typical attacks
of angina.
Lutfi et al. Trace elements and coronary disease, Sudan
Materials and Methods
We performed a cross-sectional study at the Cardiac
Catheterization Center in El-Shaab hospital, Sudan, from
November 2012 to May 2013. The patients were visited
on the intended day of the procedure before performing
cardiac catheterization. Following signed informed consent,
sociodemographic characteristics, and the medical history
(gender, age, smoking, hypertension, and diabetes mellitus) were
assessed using a questionnaire. Blood pressure was measured
using a mercury sphygmomanometer and mean arterial blood
pressure was determined as diastolic blood pressure + [(systolic
blood pressure–diastolic blood pressure)/3]. Weight and height
were measured and body mass index (BMI) was calculated using
the following formula: BMI (kg/m2) = weight (kg)/(height (m2).
Fasting blood glucose levels and the lipid profile were measured
using enzymatic methods. A 3ml volume of blood was taken and
allowed to clot. The sample was then centrifuged at 2500 rpm
for 15min at room temperature to obtain serum. The serum
was stored at −20◦C and used to measure zinc and copper
by atomic absorption spectrophotometry (SOLAAR, Atomic
Absorption Spectrophotometer; Thermo Electron, Cambridge,
UK), as previously described (Ilyas et al., 2015). Coronary
angiograms were performed by one of the authors (ABA) who
is a cardiologist. The findings of coronary angiograms were
interpreted as follows: the presence of one ormore stenoses in ≥
half of the diameter of at least one major coronary artery (left
main, right coronary, left anterior descending, and circumflex
arteries) was considered as CAD (Marroquin et al., 2004).
Data Analysis
Data were entered into a computer using SPSS for windows
version 19.0 (SPSS Inc., Chicago, IL, USA). Continuous data are
described as mean (SD) when normally distributed and median
(25–75% interquartile range) when not normally distributed.
Zinc and copper levels were not normally distributed and the
Mann–Whitney U test was used to assess significant differences
between the two groups. Linear regression analysis was
performed with zinc and copper levels as continuous dependent
variables. Sociodemographic and biochemical characteristics
were the independent variables of interest. P < 0.05 was
considered significant.
Ethics
The study received ethical clearance from the ethics review
committee at the Faculty of Medicine, University of Khartoum,
Sudan.
Results
There were 142 patients enrolled in the study. Their mean (SD)
age was 57.7 (13.1) years. The majority of the patients were males
(94, 77.5%). Of these 142 patients, 68 (48.2%) were hypertensive,
55 (39.0%) had diabetes, and 18 (12.8%) had both of these
conditions.
The general medical and biochemical characteristics of these
142 patients are shown in Table 1. The median (interquartile
range) of zinc and copper levels was 128µg/ml (103–162µg/ml)
and 156µg/ml (131–180µg/ml), respectively. Coronary
catheterization showed that 101 (71.8%) patients had CAD and
40 (28.2%) patients had patent coronary arteries. Median zinc
and copper levels were not significantly different between women
and men, obese (BMI > 30.0 kg/m2) and non-obese patients,
hypertensive and non-hypertensive patients, and diabetic and
non-diabetic patients. Similarly, there were no significant
difference in median zinc and copper levels in patients with CAD
and in those with patent coronary arteries (Table 2, Figures 1, 2).
Linear regression analysis showed that none of the
investigated factors were significantly associated with zinc
levels. However, fasting blood sugar levels (r = −0.131,
P = 0.011) and zinc levels were significantly associated with
copper levels (Table 3).
Discussion
The main findings of the current study were that 28.2%
of patients who underwent diagnostic cardiac catheterization
had patent coronary arteries. In addition, serum zinc and
copper levels were not different between CAD-negative and
CAD-positive patients. Previous reports have shown that 10–40%
of patients with anginal chest pain have normal coronary
angiograms (Vermeltfoort et al., 2010; Douglas et al., 2011).
TABLE 1 | Clinical and biochemical characteristics of the patients.
Variables Mean (SD)
Mean arterial blood pressure, mmHg 96.4 (12.2)
BMI, kg/m2 27.2 (4.9)
Hemoglobin, g/dl 13.3 (1.4)
Creatinine, mg/dl 1.8 (0.9)
White blood cells, cells /mm3 6.7251 (2.505)
Random blood sugar, mg/dl 155.4 (75.7)
Triglycerides, mg/dl 107.1 (58.4)
Cholesterol, mg/dl 150.4 (41.4)
LDL, mg/dl 86.6 (31.1)
HDL, mg/dl 39.0 (9.0)
TABLE 2 | Zinc and copper levels in the different groups of patients.
Variables n(%) Zinc µg/mL Copper µg/mL
Gender Male 94 (66.7) 130.0 (102.7–182.2) 159.7 (133.6–190.5)
Female 47 (33.3) 127.0 (103–146) 144.0 (127.0–168.0)
P 0.307 0.065
Smoking Yes 69 (48.9) 129.0 (105.0–176.0) 161.0 (134.0–187.0)
No 72 (51.1) 127.0 (102.0–158.5) 149.0 (130.0–178.5)
P 0.840 0.324
Obesity Yes 43 (30.5) 118.5 (102.7–136.0) 147.5 (130.4–169.7)
No 98 (69.5) 132.0 (102.0–176.6) 159.0 (131.0–189.0)
P 0.116 0.179
CAD Positive 40 (28.4) 118.0 (97.2–151.0) 150.6 (125.0–183.0)
Negative 101 (71.6) 130.5 (106.0–174.0) 158 (132.0–180.0)
P 0.120 0.478
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FIGURE 1 | Zinc and copper levels in patients with coronary artery
disease.
FIGURE 2 | Zinc and copper levels in males and females.
Recently, Murr et al. reported that zinc levels were not
different between patients with CAD and controls (Murr et al.,
2012). Interestingly, a previous study showed that although
serum zinc levels were not associated with the prevalence/severity
of CAD, urinary zinc loss was significantly higher in patients with
CAD and was positively associated with the severity of CAD.
Additionally, the serum zinc/24-h urine zinc ratio was inversely
associated with CAD (Giannoglou et al., 2010). However, another
TABLE 3 | Linear regression analysis of factors associated with zinc and
copper levels.
Variable Zinc level Copper level
Coefficient SE P Coefficient SE P
Age −0.239 0.487 0.625 −0.332 0.292 0.258
Gender 10.664 14.060 0.450 9.411 8.447 0.268
Mean arterial blood
pressure, mmHg
−0.145 0.371 0.697 −0.017 0.222 0.938
Smoking −7.198 10.620 0.499 3.515 6.377 0.583
BMI, kg/m2 −0.548 1.145 0.633 −0.543 0.687 0.431
Hemoglobin, g/dl 1.221 3.948 0.758 −2.832 2.366 0.234
Creatinine mg/dl −31.218 18.954 0.103 3.606 11.508 0.755
White blood cells,
cell × 103/ml l
−0.003 0.002 0.141 0.001 0.001 0.519
Fasting blood sugar,
mg/dl
0.030 0.084 0.727 −0.131 0.051 0.011
Triglycerides, mg/dl −0.010 0.107 0.925 0.101 0.064 0.116
Cholesterol, mg/dl −0.134 0.304 0.661 −0.173 0.183 0.344
LDL, mg/dl 0.418 0.332 0.212 0.146 0.201 0.468
HDL, mg/dl −0.641 0.796 0.422 0.479 0.478 0.319
Coronary artery
disease
15.421 13.704 0.263 3.875 8.262 0.640
Zinc – – – 0.355 0.060 0.000
study reported significantly lower serum levels of zinc and copper
in CAD patients compared with those with a normal angiogram
in 114 Persian patients who had a coronary catheterization
(Kazemi-Bajestani et al., 2007). Later on, only a weak positive
association between serum copper levels and calculated 10-
year coronary risk was observed in a larger Persian cohort
(Ghayour-Mobarhan et al., 2009). Although this study with a
larger cohort failed to show a significant difference in serum zinc
levels between the studied groups, the serum zinc/copper ratio
was strongly inversely associated with the 10-year coronary risk.
There is growing evidence that serum copper levels, but not zinc
levels, are positively correlated with serum levels of leptin, which
can control some CAD risk factors, such as body weight and
the serum lipid profile (Olusi et al., 2003; Mohammadzadeh and
Zarghami, 2013). Generally, low serum zinc levels are associated
with an increased prevalence of CAD as the rest of CAD risk
factors, such as diabetes, hypertension, and hypertriglyceridemia.
Increased serum copper levels have been observed in patients
with CAD (Roth and Kirchgessner, 1981; Reunanen et al., 1996;
Singh et al., 1998). Similarly, Lukaski et al. observed a slight
increase in serum copper levels, but a significant increase in urine
copper levels in patients with myocardial infarction (Lukaski
et al., 1988). Copper plays a pivotal role in atherogenesis, possibly
through its catalyst effects of low-density lipoprotein oxidation
and activation of several cholesterogenic genes in macrophages
(Esterbaur et al., 1992; Svensson et al., 2003).
An imbalance in the metabolism of zinc and copper has
been suggested to predispose to CAD. Therefore, a diet that is
deficient in copper per se or relatively deficient on comparing
to zinc, can lead to hypercholesterolemia and an increased
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susceptibility to atherosclerosis (Klevay, 1975). However, a large,
cross-sectional study (600 individuals) showed no significant
associations between serum zinc, copper, or the zinc/copper
ratio and total serum cholesterol, high-density lipoprotein,
low-density lipoprotein, or triglyceride levels (Neggers et al.,
2001).
Limitations of the current study are that neither total zinc
nor iron levels were measured and the dietary intake was not
calculated. Another limitation is the absence of an angina-free
control group for comparing between normal individuals and
those with typical angina but with a normal angiogram.
Conclusions
This small sample study shows that serum zinc and copper
levels cannot predict eventful coronary angiography if patients
experience typical anginal attacks. Further larger studies (e.g.,
longitudinal studies) are required.
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